Table 2

Cytotoxicity assay results for FLT3 inhibitors in the presence or absence of FL

Inhibitor/values, nMExogenous FL, ng/mL
01310
Lestaurtinib     
    IC50 3.3 5.3 6.3 6.8 
    IC80 7.1 11 13 15 
Midostaurin     
    IC50 7.2 14 23 25 
    IC80 17 43 59 86 
Sorafenib     
    IC50 3.3 5.9 10 12 
    IC80 7.1 16 26 34 
AC220     
    IC50 0.38 0.69 0.92 1.3 
    IC80 0.75 1.6 2.4 3.3 
KW-2449     
    IC50 28 62 85 114 
    IC80 58 166 231 296 
Inhibitor/values, nMExogenous FL, ng/mL
01310
Lestaurtinib     
    IC50 3.3 5.3 6.3 6.8 
    IC80 7.1 11 13 15 
Midostaurin     
    IC50 7.2 14 23 25 
    IC80 17 43 59 86 
Sorafenib     
    IC50 3.3 5.9 10 12 
    IC80 7.1 16 26 34 
AC220     
    IC50 0.38 0.69 0.92 1.3 
    IC80 0.75 1.6 2.4 3.3 
KW-2449     
    IC50 28 62 85 114 
    IC80 58 166 231 296 

Molm14 cells were incubated for 48 hours with increasing concentrations of FLT3 inhibitors in the presence of increasing concentrations of FL and then assayed for cytotoxic effect using an MTT assay. The concentration of drug for which the optical density was reduced to 50% or 80% of its baseline was determined using linear regression analysis of the dose-response curves after linear transformation using an exponential model. All r values in these experiments were ≥ 0.99.

Close Modal

or Create an Account

Close Modal
Close Modal